• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗逆转录病毒化学预防对资源有限环境中 HIV-1 传播的潜在影响。

Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings.

机构信息

Division of Infectious Diseases, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, United States of America.

出版信息

PLoS One. 2007 Sep 19;2(9):e875. doi: 10.1371/journal.pone.0000875.

DOI:10.1371/journal.pone.0000875
PMID:17878928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1975470/
Abstract

BACKGROUND

The potential impact of pre-exposure chemoprophylaxis (PrEP) on heterosexual transmission of HIV-1 infection in resource-limited settings is uncertain.

METHODOLOGY/PRINCIPLE FINDINGS: A deterministic mathematical model was used to simulate the effects of antiretroviral PrEP on an HIV-1 epidemic in sub-Saharan Africa under different scenarios (optimistic, neutral and pessimistic) both with and without sexual disinhibition. Sensitivity analyses were used to evaluate the effect of uncertainty in input parameters on model output and included calculation of partial rank correlations and standardized rank regressions. In the scenario without sexual disinhibition after PrEP initiation, key parameters influencing infections prevented were effectiveness of PrEP (partial rank correlation coefficient (PRCC) = 0.94), PrEP discontinuation rate (PRCC = -0.94), level of coverage (PRCC = 0.92), and time to achieve target coverage (PRCC = -0.82). In the scenario with sexual disinhibition, PrEP effectiveness and the extent of sexual disinhibition had the greatest impact on prevention. An optimistic scenario of PrEP with 90% effectiveness and 75% coverage of the general population predicted a 74% decline in cumulative HIV-1 infections after 10 years, and a 28.8% decline with PrEP targeted to the highest risk groups (16% of the population). Even with a 100% increase in at-risk behavior from sexual disinhibition, a beneficial effect (23.4%-62.7% decrease in infections) was seen with 90% effective PrEP across a broad range of coverage (25%-75%). Similar disinhibition led to a rise in infections with lower effectiveness of PrEP (< or = 50%).

CONCLUSIONS/SIGNIFICANCE: Mathematical modeling supports the potential public health benefit of PrEP. Approximately 2.7 to 3.2 million new HIV-1 infections could be averted in southern sub-Saharan Africa over 10 years by targeting PrEP (having 90% effectiveness) to those at highest behavioral risk and by preventing sexual disinhibition. This benefit could be lost, however, by sexual disinhibition and by high PrEP discontinuation, especially with lower PrEP effectiveness (< or = 50%).

摘要

背景

在资源有限的环境下,暴露前化学预防(PrEP)对艾滋病毒 1 型感染异性传播的潜在影响尚不确定。

方法/原理发现:采用确定性数学模型,在不同情景(乐观、中性和悲观)下,模拟了抗逆转录病毒 PrEP 对撒哈拉以南非洲艾滋病毒 1 型流行的影响,同时考虑了和不考虑性行为抑制。敏感性分析用于评估输入参数的不确定性对模型输出的影响,包括部分秩相关系数和标准化秩回归的计算。在没有性行为抑制的情况下,预防感染的关键参数包括 PrEP 的有效性(部分秩相关系数(PRCC)=0.94)、PrEP 停药率(PRCC=-0.94)、覆盖率(PRCC=0.92)和达到目标覆盖率的时间(PRCC=-0.82)。在有性行为抑制的情况下,PrEP 的有效性和性行为抑制的程度对预防产生了最大的影响。如果 PrEP 效果为 90%、普通人群覆盖率为 75%,则在乐观情景下,10 年后累积艾滋病毒 1 型感染人数将减少 74%,而将 PrEP 针对高危人群(占总人口的 16%),则减少 28.8%。即使高危行为因性行为抑制而增加 100%,在广泛的覆盖率(25%-75%)范围内,具有 90%有效性的 PrEP 也能产生有益效果(感染减少 23.4%-62.7%)。PrEP 效果较低(≤50%)时,类似的抑制会导致感染增加。

结论/意义:数学模型支持 PrEP 的潜在公共卫生效益。在南部撒哈拉以南非洲,通过将 PrEP(效果 90%)针对行为风险最高的人群,并防止性行为抑制,在 10 年内可避免约 270 万至 320 万例新的艾滋病毒 1 型感染。然而,性行为抑制和 PrEP 停药率高,尤其是 PrEP 效果较低(≤50%),会使这一效益丧失。

相似文献

1
Potential impact of antiretroviral chemoprophylaxis on HIV-1 transmission in resource-limited settings.抗逆转录病毒化学预防对资源有限环境中 HIV-1 传播的潜在影响。
PLoS One. 2007 Sep 19;2(9):e875. doi: 10.1371/journal.pone.0000875.
2
Factors influencing the emergence and spread of HIV drug resistance arising from rollout of antiretroviral pre-exposure prophylaxis (PrEP).影响抗逆转录病毒药物预先暴露预防(PrEP)推出后 HIV 耐药性出现和传播的因素。
PLoS One. 2011 Apr 15;6(4):e18165. doi: 10.1371/journal.pone.0018165.
3
Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.在赞比亚农村地区,使用暴露前预防(PrEP)来预防 HIV-1 感染的成本效益:一项建模研究。
PLoS One. 2013;8(3):e59549. doi: 10.1371/journal.pone.0059549. Epub 2013 Mar 18.
4
Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?在撒哈拉以南非洲地区,应在哪里部署暴露前预防(PrEP)?
Sex Transm Infect. 2013 Dec;89(8):628-34. doi: 10.1136/sextrans-2012-050891. Epub 2013 Aug 2.
5
Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.抗逆转录病毒疗法和暴露前预防:对南非 HIV 传播和耐药性的综合影响。
J Infect Dis. 2013 Jul 15;208(2):224-34. doi: 10.1093/infdis/jit150. Epub 2013 Apr 9.
6
Evaluating the potential impact and cost-effectiveness of dapivirine vaginal ring pre-exposure prophylaxis for HIV prevention.评估双夫定阴道环用于 HIV 预防的事前暴露预防的潜在影响和成本效益。
PLoS One. 2019 Jun 26;14(6):e0218710. doi: 10.1371/journal.pone.0218710. eCollection 2019.
7
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling Analysis.南非异性恋男性中 HIV 暴露前预防的成本效益:成本效用建模分析。
J Acquir Immune Defic Syndr. 2020 Jun 1;84(2):173-181. doi: 10.1097/QAI.0000000000002327.
8
Modelling impact and cost-effectiveness of oral pre-exposure prophylaxis in 13 low-resource countries.模拟口服暴露前预防在 13 个资源匮乏国家的影响和成本效益。
J Int AIDS Soc. 2020 Feb;23(2):e25451. doi: 10.1002/jia2.25451.
9
The impact of pre-exposure prophylaxis (PrEP) on HIV epidemics in Africa and India: a simulation study.暴露前预防(PrEP)对非洲和印度艾滋病流行的影响:一项模拟研究。
PLoS One. 2008 May 7;3(5):e2077. doi: 10.1371/journal.pone.0002077.
10
Evaluating the cost-effectiveness of pre-exposure prophylaxis (PrEP) and its impact on HIV-1 transmission in South Africa.评估暴露前预防(PrEP)的成本效益及其对南非 HIV-1 传播的影响。
PLoS One. 2010 Nov 5;5(11):e13646. doi: 10.1371/journal.pone.0013646.

引用本文的文献

1
From conceptualising to modelling structural determinants and interventions in HIV transmission dynamics models: a scoping review and methodological framework for evidence-based analyses.从概念化到建模 HIV 传播动力学模型中的结构决定因素和干预措施:基于证据的分析的范围综述和方法框架。
BMC Med. 2024 Sep 19;22(1):404. doi: 10.1186/s12916-024-03580-z.
2
Factors associated with PrEP adherence among MSM living in Jackson, Mississippi.居住在密西西比州杰克逊市的男男性行为者中与暴露前预防依从性相关的因素。
J HIV AIDS Soc Serv. 2021;20(3):246-261. doi: 10.1080/15381501.2021.1956666. Epub 2021 Aug 6.
3
COVID-19 information contact and participation analysis and dynamic prediction in the Chinese Sina-microblog.

本文引用的文献

1
Modeling the impact of HIV chemoprophylaxis strategies among men who have sex with men in the United States: HIV infections prevented and cost-effectiveness.模拟美国男同性恋者中HIV化学预防策略的影响:预防的HIV感染及成本效益
AIDS. 2008 Sep 12;22(14):1829-39. doi: 10.1097/QAD.0b013e32830e00f5.
2
Sequential emergence and clinical implications of viral mutants with K70E and K65R mutation in reverse transcriptase during prolonged tenofovir monotherapy in rhesus macaques with chronic RT-SHIV infection.在慢性RT-SHIV感染的恒河猴长期接受替诺福韦单药治疗期间,逆转录酶中具有K70E和K65R突变的病毒突变体的相继出现及其临床意义。
Retrovirology. 2007 Apr 6;4:25. doi: 10.1186/1742-4690-4-25.
3
中国新浪微博上的新冠疫情信息接触、参与分析及动态预测
Physica A. 2021 May 15;570:125788. doi: 10.1016/j.physa.2021.125788. Epub 2021 Jan 29.
4
Quantifying the Influence of Delay in Opinion Transmission of COVID-19 Information Propagation: Modeling Study.量化 COVID-19 信息传播中意见延迟的影响:建模研究。
J Med Internet Res. 2021 Feb 12;23(2):e25734. doi: 10.2196/25734.
5
Modeling and analyzing cross-transmission dynamics of related information co-propagation.建模与分析相关信息共传播的跨传播动力学。
Sci Rep. 2021 Jan 11;11(1):268. doi: 10.1038/s41598-020-79503-8.
6
"It's hard for us men to go to the clinic. We naturally have a fear of hospitals." Men's risk perceptions, experiences and program preferences for PrEP: A mixed methods study in Eswatini.对于我们男性来说,去诊所很难。我们天生对医院有一种恐惧。” 斯威士兰男性对 PrEP 的风险认知、经验和项目偏好:一项混合方法研究。
PLoS One. 2020 Sep 23;15(9):e0237427. doi: 10.1371/journal.pone.0237427. eCollection 2020.
7
A Mobile Gaming Intervention for Persons on Pre-Exposure Prophylaxis: Protocol for Intervention Development and Randomized Controlled Trial.一项针对暴露前预防人群的移动游戏干预措施:干预开发与随机对照试验方案
JMIR Res Protoc. 2020 Sep 14;9(9):e18640. doi: 10.2196/18640.
8
Quantify the role of superspreaders -opinion leaders- on COVID-19 information propagation in the Chinese Sina-microblog.量化超级传播者(意见领袖)在 COVID-19 信息传播中的作用,中国新浪微博。
PLoS One. 2020 Jun 8;15(6):e0234023. doi: 10.1371/journal.pone.0234023. eCollection 2020.
9
Introducing pre-exposure prophylaxis to prevent HIV acquisition among men who have sex with men in Sweden: insights from a mathematical pair formation model.在瑞典,通过引入暴露前预防措施来预防男男性行为者感染 HIV:基于数学对偶形成模型的见解。
BMJ Open. 2020 Feb 5;10(2):e033852. doi: 10.1136/bmjopen-2019-033852.
10
Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study.在南非,为注射式避孕使用者提供长效暴露前预防措施以预防 HIV 的流行病学影响和成本效益:一项建模研究。
J Int AIDS Soc. 2019 Dec;22(12):e25427. doi: 10.1002/jia2.25427.
K65R development among subtype C HIV-1-infected patients in tenofovir DF clinical trials.
在替诺福韦酯临床试验中,C亚型HIV-1感染患者中K65R的演变情况。
AIDS. 2007 Jan 11;21(2):265-6. doi: 10.1097/QAD.0b013e32801199ee.
4
The fitness cost of mutations associated with human immunodeficiency virus type 1 drug resistance is modulated by mutational interactions.与1型人类免疫缺陷病毒耐药性相关的突变的适合度代价受突变相互作用的调节。
J Virol. 2007 Mar;81(6):3037-41. doi: 10.1128/JVI.02712-06. Epub 2006 Dec 27.
5
Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004.2004年HIV-1基因亚型和重组体的全球及区域分布情况。
AIDS. 2006 Oct 24;20(16):W13-23. doi: 10.1097/01.aids.0000247564.73009.bc.
6
High prevalence of the K65R mutation in human immunodeficiency virus type 1 subtype C isolates from infected patients in Botswana treated with didanosine-based regimens.在博茨瓦纳接受基于去羟肌苷方案治疗的感染患者中,1型人类免疫缺陷病毒C亚型分离株中K65R突变的高流行率。
Antimicrob Agents Chemother. 2006 Dec;50(12):4182-5. doi: 10.1128/AAC.00714-06. Epub 2006 Oct 2.
7
In vitro human immunodeficiency virus type 1 resistance selections with combinations of tenofovir and emtricitabine or abacavir and lamivudine.使用替诺福韦与恩曲他滨组合或阿巴卡韦与拉米夫定组合进行1型人类免疫缺陷病毒的体外耐药性筛选。
Antimicrob Agents Chemother. 2006 Dec;50(12):4087-95. doi: 10.1128/AAC.00816-06. Epub 2006 Sep 18.
8
Chemoprophylaxis with tenofovir disoproxil fumarate provided partial protection against infection with simian human immunodeficiency virus in macaques given multiple virus challenges.在多次受到病毒攻击的猕猴中,使用替诺福韦酯进行化学预防可提供部分保护,防止感染猿猴人类免疫缺陷病毒。
J Infect Dis. 2006 Oct 1;194(7):904-11. doi: 10.1086/507306. Epub 2006 Aug 29.
9
Adherence to antiretroviral therapy in sub-Saharan Africa and North America: a meta-analysis.撒哈拉以南非洲地区和北美地区对抗逆转录病毒疗法的依从性:一项荟萃分析。
JAMA. 2006 Aug 9;296(6):679-90. doi: 10.1001/jama.296.6.679.
10
The potential impact of male circumcision on HIV in Sub-Saharan Africa.男性包皮环切术对撒哈拉以南非洲地区艾滋病毒的潜在影响。
PLoS Med. 2006 Jul;3(7):e262. doi: 10.1371/journal.pmed.0030262.